Related references
Note: Only part of the references are listed.The Interaction between 30b-5p miRNA and MBNL1 mRNA is Involved in Vascular Smooth Muscle Cell Differentiation in Patients with Coronary Atherosclerosis
Chin Cheng Woo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A novel long non-coding RNA TONSL-AS1 regulates progression of gastric cancer via activating TONSL
Peng Wang et al.
EXPERIMENTAL CELL RESEARCH (2019)
Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling via Oncogenes YBX1, MET, and p21 in Lung Cancer
Wenmei Su et al.
CANCER RESEARCH (2018)
Association of miR-197-5p, a Circulating Biomarker for Heart Failure, with Myocardial Fibrosis and Adverse Cardiovascular Events among Patients with Stage C or D Heart Failure
Wei Liu et al.
CARDIOLOGY (2018)
The Function and Therapeutic Potential of Long Non-coding RNAs in Cardiovascular Development and Disease
Clarissa P. C. Gomes et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers
J. Remon et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2016)
Long Non-Coding RNAs as Master Regulators in Cardiovascular Diseases
Krystal Archer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
miRNA-197 and miRNA-223 Predict Cardiovascular Death in a Cohort of Patients with Symptomatic Coronary Artery Disease
Christian Schulte et al.
PLOS ONE (2015)
Reciprocal control of miR-197 and IL-6/STAT3 pathway reveals miR-197 as potential therapeutic target for hepatocellular carcinoma
Huamin Wang et al.
ONCOIMMUNOLOGY (2015)
Noncoding RNAs in vascular disease
Amy Leung et al.
CURRENT OPINION IN CARDIOLOGY (2014)
Cardiovascular remodelling in coronary artery disease and heart failure
Gerd Heusch et al.
LANCET (2014)
Integrative Genomics Reveals Novel Molecular Pathways and Gene Networks for Coronary Artery Disease
Ville-Petteri Makinen et al.
PLOS GENETICS (2014)
Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease Role of High-Density Lipoprotein-Proteome Remodeling
Meliana Riwanto et al.
CIRCULATION (2013)
Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease
Christian Besler et al.
EMBO MOLECULAR MEDICINE (2012)
β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease
Sripal Bangalore et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?
Aneta Otocka-Kmiecik et al.
PROGRESS IN LIPID RESEARCH (2012)
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Leonardo Salmena et al.
CELL (2011)
Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease
Seung-Jung Park et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Prognostic Value of 64-Slice Cardiac Computed Tomography Severity of Coronary Artery Disease, Coronary Atherosclerosis, and Left Ventricular Ejection Fraction
Benjamin J. W. Chow et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis
Steven D. Nathan et al.
RESPIRATORY MEDICINE (2010)
Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease
William R. Hiatt et al.
VASCULAR MEDICINE (2010)
Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs
DP Bartel et al.
NATURE REVIEWS GENETICS (2004)